{"id":4226,"date":"2024-04-02T11:48:30","date_gmt":"2024-04-02T08:48:30","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=4226"},"modified":"2026-10-30T13:29:44","modified_gmt":"2026-10-30T11:29:44","slug":"participation-of-iasis-pharma-in-the-22nd-panhellenic-diabetes-congress","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/participation-of-iasis-pharma-in-the-22nd-panhellenic-diabetes-congress\/","title":{"rendered":"PARTICIPATION OF IASIS PHARMA IN THE \u201c22nd PANHELLENIC DIABETES CONGRESS\u201d"},"content":{"rendered":"<p><strong>Athens, 27 \u2013 30\/03\/2024,<\/strong><\/p>\n<p><b>Divani Caravel Hotel<\/b><\/p>\n<p><strong>IASIS PHARMA<\/strong> participated at the <strong>\u201c22nd PANHELLENIC DIABETES CONGRESS\u201d<\/strong>, held in Athens, at the <strong>Divani Caravel Hotel<\/strong>, showing its active interest in Diabetes Mellitus disease, promoting cornerstone pharmaceutical products for type 2 diabetes. Moreover, <strong>IASIS PHARMA<\/strong> is about to invest significantly in T2DM in the near future, launching more than 4 original products.<\/p>\n<p>The conference took place on <strong>March 27 to 30, 2024<\/strong>, with the participation of more than 2,000 Health Care Professionals.<\/p>\n<p>The event is aimed at Pathologists, General Practitioners, Endocrinologists &amp; Nephrologists. Also, it consists of a wide range of topics and is held in parallel halls.<\/p>\n<p><strong>IASIS PHARMA<\/strong> participated in the event with an exhibition stand, where experts had the opportunity to visit and learn about the range of high-quality proprietary pharmaceuticals available from the company.<\/p>\n<p>At <strong>IASIS PHARMA exhibition stand<\/strong>, the following products were presented:<\/p>\n<ul>\n<li><strong>RosuZet<sup>\u00ae<\/sup><\/strong>:\u00a0<strong>New Product Launching<\/strong>. Fixed-dose combination of <strong>Rosuvastatin &amp; Ezetimibe<\/strong>, in a single dosage form, in packages of\u00a0 30 f.c. tabs available in the full spectrum of strengths: (Rosuvastatin \/ Ezetimibe) 5 \/ 10mg, 10 \/ 10mg, 20 \/ 10mg, 40 \/ 10mg.<\/li>\n<li><strong>Rami<\/strong><strong>&#8211;<\/strong><strong>Amlo<sup>\u00ae<\/sup><\/strong><strong>:<\/strong> a fixed-dose combination of\u00a0<strong>Ramipril &amp; Amlodipine<\/strong>\u00a0in a single dosage form, in packages of 28 capsules, available in 4 strengths: (Ramipril \/ Amlodipine) 5mg \/ 5mg, \u00a05mg \/ 10mg, 10mg \/ 5mg, 10mg \/ 10mg<\/li>\n<li><strong>Rami<\/strong><strong>&#8211;<\/strong><strong><strong>Amlo\u00a0plus<sup>\u00ae<\/sup>,\u00a0<\/strong><\/strong>also an original fixed-dose combination of <strong>Ramipril \u2013 Amlodipine \u2013Hydrochlorothiazide<\/strong>, which is available in packages of 30 capsules, in a wide range of strengths: (Ramipril \/ Amlodipine \/ Hydrochlorothiazide) 5 mg \/ 5 mg \/ 12,5 mg, 5 mg \/ 5 mg \/ 25 mg, 10 mg \/ 5 mg \/ 25 mg, 10 mg \/ 10 mg \/ 25 mg.<\/li>\n<li><strong><strong>Glucofree<sup>\u00ae<\/sup>:<sup>\u00a0<\/sup><\/strong><\/strong>Each film-coated tablet contains <strong>850 mg Metformin hydrochloride<\/strong>, equivalent to 662,9 mg metformin respectively (box of <strong>60<\/strong> f.c. tabs).<\/li>\n<li><strong><strong>Glucoplus<sup>\u00ae<\/sup>:<sup>\u00a0<\/sup><\/strong><\/strong>Each film-coated tablet contains <strong>1000 mg Metformin hydrochloride<\/strong>, equivalent to 780mg Metformin respectively (box of <strong>60<\/strong> f.c. tabs).<\/li>\n<li><strong>MAG<\/strong><strong>&#8211;<\/strong><strong>IASIS<sup>\u00ae<\/sup><\/strong><strong>:<\/strong> the first uniquely effective combination of 1193.57 mg Magnesium <strong>citrate<\/strong> &amp; 667.56 mg Magnesium <strong>aspartate<\/strong>, equivalent to <strong>243 mg Magnesium<\/strong>, indicated for magnesium deficiency, in the form of <strong>40 effervescent tablets<\/strong>.<\/li>\n<li><\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"alignleft wp-image-4220\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/04\/\u0394\u0392\u03a4-24-FOR-SITE-copy.png\" alt=\"\u0394\u03a4\u0392 - 24\" width=\"526\" height=\"592\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Athens, 27 \u2013 30\/03\/2024, Divani Caravel Hotel IASIS PHARMA participated at the \u201c22nd PANHELLENIC DIABETES CONGRESS\u201d, held in Athens, at the Divani Caravel Hotel, showing its active interest in Diabetes Mellitus disease, promoting cornerstone pharmaceutical products for type 2 diabetes. Moreover, IASIS PHARMA is about to invest significantly in T2DM in the near future, launching  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157,204],"tags":[],"class_list":["post-4226","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-16a","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=4226"}],"version-history":[{"count":8,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4226\/revisions"}],"predecessor-version":[{"id":4234,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4226\/revisions\/4234"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=4226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=4226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=4226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}